Snippet from the article:
A vaccine treatment for prostate cancer has become the first therapy of its kind to win approval for use in U.S. patients.
The U.S. Food and Drug Administration approved Provenge, a novel technique for fighting prostate cancer, on Thursday. The treatment involves taking a patient’s own white blood cells and using a drug that trains them to more actively attack cancer cells.
Read the full article — ‘Landmark’ cancer vaccine gets FDA approval